ProfileGDS4718 / 223345_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 52% 54% 56% 55% 54% 53% 54% 55% 51% 57% 53% 49% 54% 65% 61% 59% 53% 59% 55% 60% 54% 49% 55% 56% 54% 60% 51% 56% 55% 54% 49% 54% 54% 58% 63% 52% 51% 52% 53% 53% 57% 51% 53% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6303452
GSM549102patient 115, normal, homogenized [OPG study]5.7587654
GSM549104patient 119, normal, homogenized [OPG study]5.8729356
GSM549108patient 138, normal, homogenized [OPG study]5.8669155
GSM549119patient 077, normal, homogenized [OPG study]5.7653254
GSM549133patient 032, cancer, homogenized [OPG study]5.6647453
GSM549139patient 042, cancer, homogenized [OPG study]5.7499554
GSM549099patient 107, normal, homogenized [OPG study]5.8121655
GSM549109patient 139, normal, homogenized [OPG study]5.6165251
GSM549110patient 046, normal, homogenized [OPG study]5.9273757
GSM549114patient 063, normal, homogenized [OPG study]5.6648253
GSM549122patient 082, normal, homogenized [OPG study]5.4596249
GSM549134patient 033, cancer, homogenized [OPG study]5.7227554
GSM549136patient 036, cancer, homogenized [OPG study]6.523665
GSM549140patient 044, cancer, homogenized [OPG study]6.1836461
GSM549111patient 047, normal, homogenized [OPG study]6.0336559
GSM549113patient 057, normal, homogenized [OPG study]5.6659753
GSM549132patient 031, cancer, homogenized [OPG study]6.0200659
GSM549137patient 038, cancer, homogenized [OPG study]5.7784755
GSM549142patient 047, cancer, homogenized [OPG study]6.2329860
GSM549100patient 110, normal, homogenized [OPG study]5.7621354
GSM549107patient 135, normal, homogenized [OPG study]5.4111149
GSM549115patient 068, normal, homogenized [OPG study]5.7574755
GSM549116patient 072, normal, homogenized [OPG study]5.8578356
GSM549120patient 078, normal, homogenized [OPG study]5.7578254
GSM549131patient 030, cancer, homogenized [OPG study]6.1354360
GSM549118patient 074, normal, homogenized [OPG study]5.5906551
GSM549129patient 027, cancer, homogenized [OPG study]5.9129556
GSM549123patient 088, normal, homogenized [OPG study]5.817455
GSM549124patient 006, cancer, homogenized [OPG study]5.7684654
GSM549126patient 015, cancer, homogenized [OPG study]5.4537749
GSM549128patient 025, cancer, homogenized [OPG study]5.7234854
GSM549103patient 117, normal, homogenized [OPG study]5.7990354
GSM549117patient 073, normal, homogenized [OPG study]5.9433258
GSM549138patient 041, cancer, homogenized [OPG study]6.3670663
GSM549141patient 045, cancer, homogenized [OPG study]5.601352
GSM549130patient 028, cancer, homogenized [OPG study]5.5885351
GSM549101patient 111, normal, homogenized [OPG study]5.6494152
GSM549105patient 128, normal, homogenized [OPG study]5.7149253
GSM549106patient 134, normal, homogenized [OPG study]5.6242353
GSM549112patient 048, normal, homogenized [OPG study]5.9004257
GSM549125patient 011, cancer, homogenized [OPG study]5.5528651
GSM549127patient 024, cancer, homogenized [OPG study]5.7341853
GSM549135patient 035, cancer, homogenized [OPG study]5.7702755